• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by The Beauty Health Company

    9/8/25 9:53:08 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care
    Get the next $SKIN alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 1)


    Beauty Health Company

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)


    88331L108

    (CUSIP Number)


    04/30/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    88331L108


    1Names of Reporting Persons

    Mirabella Financial Services LLP
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED KINGDOM
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    12,790,383.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    12,790,383.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    12,790,383.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    10.21 %
    12Type of Reporting Person (See Instructions)

    IA


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Beauty Health Company
    (b)Address of issuer's principal executive offices:

    2165 Spring Street, Long Beach, CA 90806
    Item 2. 
    (a)Name of person filing:

    Mirabella Financial Services LLP
    (b)Address or principal business office or, if none, residence:

    11 Strand, London, WC2N 5HR
    (c)Citizenship:

    United Kingdom
    (d)Title of class of securities:

    Common Stock
    (e)CUSIP No.:

    88331L108
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    12,790,383
    (b)Percent of class:

    10.21  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    12,790,383

     (ii) Shared power to vote or to direct the vote:

    0

     (iii) Sole power to dispose or to direct the disposition of:

    12,790,383

     (iv) Shared power to dispose or to direct the disposition of:

    0

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    The shares are reported on behalf of Blue Riband Fund LP for which Mirabella Financial Services LLP acts as the Investment Manager. Mirabella has discretion to procedure the exercise of voting and dispositive power over the shares.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Mirabella Financial Services LLP
     
    Signature:Suzanne Porter
    Name/Title:Suzanne Porter | Chief Compliance Officer
    Date:09/08/2025
    Get the next $SKIN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SKIN

    DatePrice TargetRatingAnalyst
    11/15/2023$11.00 → $1.50Buy → Hold
    Jefferies
    11/14/2023$10.00 → $2.50Buy → Hold
    Canaccord Genuity
    11/14/2023Neutral → Underweight
    JP Morgan
    11/14/2023$12.00 → $2.00Overweight → Underweight
    Piper Sandler
    11/14/2023$9.00 → $2.50Outperform → Market Perform
    TD Cowen
    11/14/2023Buy → Hold
    The Benchmark Company
    11/14/2023Mkt Perform → Underperform
    Raymond James
    11/14/2023Outperform → Mkt Perform
    William Blair
    More analyst ratings

    $SKIN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MULTIMEDIA UPDATE -- Hydrafacial Launches Inaugural Hydrafacial Advisory Councils & Ambassador Network to Fuel Next-Era Innovation and Growth

    LONG BEACH, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announces the launch of the Hydrafacial Advisory Councils and Ambassador Network – a prestigious collective of plastic surgeons, dermatologists, aesthetic practitioners, and estheticians selected for their expertise and influence in the aesthetic industry. The formation of the Hydrafacial Advisory Councils and Ambassador Network reinforces Hydrafacial's long-standing commitment to its provider community, ensuring the brand's innovation pipeline, education programs, and clinical research remain grounded in real-world insights and excellence in care.

    9/9/25 9:38:56 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    Hydrafacial Launches Inaugural Hydrafacial Advisory Councils & Ambassador Network to Fuel Next-Era Innovation and Growth

    LONG BEACH, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announces the launch of the Hydrafacial Advisory Councils and Ambassador Network – a prestigious collective of plastic surgeons, dermatologists, aesthetic practitioners, and estheticians selected for their expertise and influence in the aesthetic industry. The formation of the Hydrafacial Advisory Councils and Ambassador Network reinforces Hydrafacial's long-standing commitment to its provider community, ensuring the brand's innovation pipeline, education programs, and clinical research remain grounded in real-world insights and excellence in care.

    9/9/25 8:00:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    BeautyHealth Reports Second Quarter 2025 Financial Results

    Raises guidance on strong execution and disciplined cost management Advances science-backed innovation with successful launch of the HydraFillic with Pep9™ Booster LONG BEACH, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the second quarter ended June 30, 2025 ("Q2 2025"). "Momentum continued to build in the second quarter, as BeautyHealth delivered another strong performance aligned with our strategic transformation goals," said BeautyHealth CEO Marla Beck. "We exceeded revenue and Adjusted EBITDA expectations and raised the full year ou

    8/7/25 4:05:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    The Beauty Health Company downgraded by Jefferies with a new price target

    Jefferies downgraded The Beauty Health Company from Buy to Hold and set a new price target of $1.50 from $11.00 previously

    11/15/23 7:13:27 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    The Beauty Health Company downgraded by JP Morgan

    JP Morgan downgraded The Beauty Health Company from Neutral to Underweight

    11/14/23 7:45:38 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    The Beauty Health Company downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded The Beauty Health Company from Buy to Hold and set a new price target of $2.50 from $10.00 previously

    11/14/23 7:45:38 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by The Beauty Health Company

    SCHEDULE 13G/A - Beauty Health Co (0001818093) (Subject)

    9/8/25 9:53:08 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    The Beauty Health Company filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Beauty Health Co (0001818093) (Filer)

    9/4/25 4:28:08 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by The Beauty Health Company

    SCHEDULE 13G/A - Beauty Health Co (0001818093) (Subject)

    8/14/25 10:46:39 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman Saunders Brent L bought $43,686 worth of shares (40,450 units at $1.08), increasing direct ownership by 0.69% to 5,921,769 units (SEC Form 4)

    4 - Beauty Health Co (0001818093) (Issuer)

    8/13/24 5:00:11 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Financials

    Live finance-specific insights

    View All

    BeautyHealth Reports Second Quarter 2025 Financial Results

    Raises guidance on strong execution and disciplined cost management Advances science-backed innovation with successful launch of the HydraFillic with Pep9™ Booster LONG BEACH, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the second quarter ended June 30, 2025 ("Q2 2025"). "Momentum continued to build in the second quarter, as BeautyHealth delivered another strong performance aligned with our strategic transformation goals," said BeautyHealth CEO Marla Beck. "We exceeded revenue and Adjusted EBITDA expectations and raised the full year ou

    8/7/25 4:05:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    BeautyHealth to Report Second Quarter 2025 Financial Results on August 7, 2025

    LONG BEACH, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report second quarter 2025 financial results after market close on Thursday, August 7, 2025. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the Company's investor relations website at https://investors.beautyhealth.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure InformationThe Beauty Health Company announce

    7/24/25 10:00:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    BeautyHealth Reports First Quarter 2025 Financial Results

    LONG BEACH, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2025 ("Q1 2025"). "Our first quarter results reflect strong execution and continued momentum in our transformation strategy," said CEO Marla Beck. "We exceeded both revenue and adjusted EBITDA guidance, driven by gross profit growth and meaningful cost efficiencies. Despite macroeconomic pressures that impacted device sales, consumables revenue remained resilient, reinforcing the strength of our recurring revenue model and sustained consumer dem

    5/8/25 4:05:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Leadership Updates

    Live Leadership Updates

    View All

    The Beauty Health Company Strengthens Commercial Leadership Team with Chief Revenue Officer and Chief Marketing Officer Appointments

    The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of two accomplished industry executives to its commercial leadership team. Ron Menezes will join Beauty Health as Chief Revenue Officer and Carrie Caulkins will join the Company as Chief Marketing Officer, effective October 15, 2024, with both reporting to the Company's Chief Executive Officer, Marla Beck. Mr. Menezes assumes his new role from Dan ("Doc") Watson, who is leaving Beauty Health and will assist with the transition through year-end. Ms. Caulkins fills an open position. Marla Beck commented on the appointments, "We are thrilled to welcome Ron and Carrie to the executive t

    10/15/24 4:10:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    BeautyHealth Names Sheri Lewis as Chief Supply Chain and Operations Officer

    The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced that it has appointed Sheri Lewis as Chief Supply Chain and Operations Officer, effective immediately. Ms. Lewis will report to BeautyHealth's President and Chief Executive Officer, Marla Beck. "Sheri is a talented and deeply experienced executive who brings decades of valuable global operations expertise to BeautyHealth as we chart the future of the Company," said Marla Beck, BeautyHealth President and Chief Executive Officer. "The Board of Directors and I are confident that her deep industry experience across global supply chain and operations will play a critical role in advancing our strategic

    4/9/24 4:10:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    BeautyHealth Announces Appointment Of Marla Beck As Chief Executive Officer

    The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced its Board of Directors has unanimously approved Marla Beck as the Company's permanent President and Chief Executive Officer. Ms. Beck has been Interim CEO since November 20, 2023, in addition to serving on the Company's Board of Directors, which she will continue to do going forward. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240312423257/en/SKIN) (Photo: Business Wire)">Marla Beck, President and Chief Executive Officer, The Beauty Health Company (NASDAQ:SKIN) (Photo: Business Wire) "Over the past few months, the Board has undertaken

    3/12/24 4:05:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

    SC 13G/A - Beauty Health Co (0001818093) (Subject)

    11/14/24 4:16:27 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

    SC 13G/A - Beauty Health Co (0001818093) (Subject)

    11/14/24 11:27:23 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

    SC 13G/A - Beauty Health Co (0001818093) (Subject)

    11/14/24 11:03:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Monahan Michael P. covered exercise/tax liability with 32,357 shares, decreasing direct ownership by 2% to 1,326,305 units (SEC Form 4)

    4 - Beauty Health Co (0001818093) (Issuer)

    8/12/25 4:17:27 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    Director Gruber Desiree was granted 73,051 shares, increasing direct ownership by 61% to 192,565 units (SEC Form 4)

    4 - Beauty Health Co (0001818093) (Issuer)

    6/18/25 4:34:50 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    Chairman Saunders Brent L was granted 73,051 shares, increasing direct ownership by 1% to 5,994,820 units (SEC Form 4)

    4 - Beauty Health Co (0001818093) (Issuer)

    6/18/25 4:34:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care